When was Octavius Pharma founded?

Octavius Pharma was founded in 2004.

Where is Octavius Pharma located?

Octavius Pharma is headquartered in Ahmedabad, India. It is registered at 407-A, PRIMATE HOUSE, OPP. MOTHER MILK PALACE, NR. JUDGES BUNGLOWS, BODAKDEV, Ahmedabad, AHMEDABAD, Gujarat, India, 380015.

How many employees does Octavius Pharma have?

As of Jun 30, 2026, the latest employee count at Octavius Pharma is 29.

Is Octavius Pharma a funded company?

Octavius Pharma is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of Octavius Pharma?

Annual revenue of Octavius Pharma is between ₹10 Cr and ₹50 Cr as on Mar 31, 2025

Where does Octavius Pharma rank among its competitors?

Octavius Pharma ranks 59th amongst 439 active competitors, of which 16 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Nucleus RadioPharma, which secured an undisclosed amount in Jun, 2024.

Who are the top competitors of Octavius Pharma?

Octavius Pharma's top competitors include Concord Biotech, Aizant and Almac Group. Among them, Nucleus RadioPharma secured the most recent funding round in June, 2024.

Octavius Pharma - 2026 Company Profile, Competitors & Financials

Company Details

Manufacturer of soap strips and hygiene products. The company produces a variety of hygiene products, including soap strips in different formats, sanitizers, and naphthalene balls. These products are designed for convenience and effectiveness in maintaining hygiene. The manufacturing process emphasizes quality ingredients and formulations to ensure product efficacy and a pleasant user experience. The company's focus is on providing accessible and affordable hygiene solutions.

Website: octaviuspharma.com
Social
Registered Address: 407-A, PRIMATE HOUSE, OPP. MOTHER MILK PALACE, NR. JUDGES BUNGLOWS, BODAKDEV, Ahmedabad, AHMEDABAD, Gujarat, India, 380015

Key Metrics

Founded Year

2004

Location

Ahmedabad, India

Stage

Unfunded

Ranked

59^th among 439 active competitors

Annual Revenue

₹10 - ₹50 Cr as on Mar 31, 2025

Employee Count

29 as on Jun 30, 2026

Similar Companies

Concord Biotech & 447 more

View Octavius Pharma's full profile

Octavius Pharma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
OCTAVIUS PHARMA PRIVATE LIMITED CIN: U24231GJ2004PTC044024 , India, Active	Apr 23, 2004	₹10 - ₹50 Cr (As on Mar 31, 2025)	-

Octavius Pharma has not raised any funding rounds yet.

Octavius Pharma's employee count trend

Octavius Pharma has 29 employees as of Jun 26. Here is Octavius Pharma's employee count trend over the years:

Employee count trend for Octavius Pharma

Uncover Octavius Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Octavius Pharma include Concord Biotech, Aizant and Almac Group. Here is the list of Top 10 competitors of Octavius Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Concord Biotech 2000, Ahmedabad (India), Public	CDMO focused on manufacturing API	-	Quadria Capital, Helix Investments & 18 others	65/100
2nd	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$16.8M	Zephyr Management, Zephyr Peacock & 39 others	60/100
3rd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	57/100
4th	Nucleus RadioPharma 2022, Rochester (United States), Series A	CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services	$72.1M	Eclipse, AstraZeneca & 7 others	54/100
5th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
6th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	53/100
7th	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	53/100
8th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
9th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	51/100
10th	Aptuit 2004, Greenwich (United States), Acquired	Pioneering drug discovery and development, accelerating concept to cure	$14.2M	Temasek, Welsh, Carson, Anderson & Stowe & 1 others	50/100
59th	Octavius Pharma 2004, Ahmedabad (India), Unfunded	Manufacturer of soap strips and hygiene products	-	-	39/100